OPPO Research Institute Calls for Innovative Proposals on Inclusion and Health with a Total Grant of up to USD $460,000
DGAP-News: Oppo / Key word(s): Miscellaneous OPPO Research Institute Calls for Innovative Proposals on Inclusion and Health with a Total Grant of up to USD $460,000 09.05.2022 / 10:30 The issuer is solely responsible for the content of this announcement.
OPPO Research Institute Calls for Innovative Proposals on Inclusion and Health with a Total Grant of up to USD $460,000
SHENZHEN, CHINA - Media OutReach - 9 May 2022 - OPPO today announced the OPPO Research Institute Innovation Accelerator to empower technology professionals and entrepreneurs that inspiration matters to bring innovative solutions to life and create a better future together, based on the brand value proposition of "Inspiration Ahead". The Innovation Accelerator is being held by the OPPO Research Institute and Microsoft for Startups as a strategic partner. The program aims to encourage all technology innovators to solve some of the most pressing issues facing humanity even amid times of uncertainty.
OPPO Research Institute Innovation Accelerator – Inspiration Matters
Centered on the theme of ‘Virtuous Innovation’, OPPO is looking to recruit proposals under two entry categories — Accessible Technology and Digital Health. Following the evaluation of proposals submitted by participating teams or individuals, up to ten proposals will be awarded grants of USD $46,000 each, as well as further opportunities for investment opportunities, technical support, research and commercial partnerships, and promotion at global events.
“OPPO believes deeply in the idea of ‘Virtuous Innovation’. As we continue to explore new technology, we remain dedicated to doing so in a way that puts people first. Through technology, we are attempting to solve some of the biggest issues facing humanity so that we can create a better world for all,” said Levin Liu, Vice President and Head of the OPPO Research Institute. “With the severity of global issues like aging populations, poor public health, and digital divide increasing day by day, we could not rely on our own efforts to provide solutions. We have therefore initiated the Innovation Accelerator to empower likeminded innovators to solve these big issues together with us using the power of technology.”
Grants and technical support aim to help promising entrepreneurs realize their visions The 2022 Innovation Accelerator will open online applications beginning May 8, 2022, and winners will be announced after three months of preliminary evaluations and Demo Day roadshows. OPPO will provide all winning teams or individuals with a financial grant, as well as support to help them further implement and promote their ideas. Each winning proposal will be entitled to the following incentives:
Approximately USD $46,000 (300,000 RMB) in grants
Partnership and funding opportunities
Commercialization of the proposed via integration with OPPO products
Publicity and demo opportunities at global tech events
Support from OPPO’s R&D team including opportunities to meet and present ideas to industry professionals
Proposals will be evaluated under the supervision of a professional Judging Committee, where they will be assessed against their ability to meet four key criteria: Feasibility, Innovation & Originality, Social Value, and Long-term Potential. OPPO also invited a judging committee of experts, academics, and senior professionals in the field of technology and innovation to help identify and accelerate the development of high-potential proposals.
“Startups are home to a whole trove of innovative technologies that can provide innovative digital solutions to various industries,” said James Chou, CEO and Managing Director of Microsoft for Startups, Greater China Region, Japan, and Korea. “With a decade of experience in China, Microsoft for Startups is dedicated to building an open and collaborative platform for startups and established companies to innovate together. We look forward to working with leading smartphone brand OPPO to develop innovative solutions for a variety of industries, as well as helping research and commercial applications support each other.”
OPPO has also established a separate referral award to encourage members of the public to refer outstanding innovation cases for consideration by the Innovation Accelerator Judging Committee. Members of the public can submit referrals through the OPPO website during the application stage, with prizes available for every successful proposal that makes it through the preliminary evaluation, Demo Day, and finalist stages.
In addition, OPPO is planning three international roadshows in Hyderabad, India, Tel Aviv, Israel and the United States.
OPPO joins force with likeminded partners to deliver ‘Inspiration Ahead’ Spirit Since its onset at the start of 2020, the global Covid-19 pandemic has disrupted the lives of billions of people around the world. At the same time, the fast development of technology is leaving certain disadvantage groups behind, creating new challenges for them as a result. As a company that takes its responsibility and commitments to society to heart through its brand mission of ‘Technology for Mankind, Kindness for the World’, OPPO hopes to address these issues and others like them through technology, helping to bring greater happiness and wellbeing to more people.
Through its continued pursuit of ‘Virtuous Innovation’, OPPO has accumulated rich experience and expertise in accessible technology and digital health, including extensive user insights and applications. Among these are its work into accessible design and adaptation for elderly users, for example its Color Vision Enhancement technology on the Find X3 series, which assists users with color vision deficiencies. With ColorOS operating system and other products, OPPO has also introduced user interfaces adapted specifically for elderly users, enabling them to enjoy the benefits and convenience of technology.
In order to facilitate health management among global users, OPPO has also founded the OPPO Health Lab, partnering with professional medical institutions and sports academies to develop innovative digital health products in both hardware and software. Through its research and development, OPPO hopes to help people improve their health through preventive healthcare.
OPPO knows that its power to change to world as single organization is limited. Through the Innovation Accelerator, OPPO hopes to connect with other likeminded individuals, teams, and organizations to identify and develop high-potential solutions so that they can benefit those who most need them. OPPO intends to build the Innovation Accelerator into a long-term platform that addresses the most pressing public issues by attracting the best solutions from the brightest minds around the world, ultimately enabling more people to benefit from Virtuous Innovation.
Applications for the OPPO Innovation Accelerator will be open from May 8 to June 30, 2022. To submit a proposal, refer a proposal, or learn more about the program, please visit the official OPPO Innovation Accelerator website at oppo.com/en/proposal/
About OPPO OPPO is a leading global smart device brand. Since the launch of its first mobile phone - “Smiley Face” - in 2008, OPPO has been in relentless pursuit of the perfect synergy of aesthetic satisfaction and innovative technology. Today, OPPO provides a wide range of smart devices spearheaded by the Find and Reno series. Beyond devices, OPPO provides its users with the ColorOS operating system and internet services like OPPO Cloud and OPPO+. OPPO operates in more than 50 countries and regions with more than 40,000 of OPPO's employees are dedicated to creating a better life for customers around the world.
firstname.lastname@example.org All times are China Standard Time (UTC +8).
09.05.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting
Global Sustainable Packaging Market Global Sustainable Packaging Market Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Sustainable Packaging: Global Markets" report has been added to ResearchAndMarkets.com's offering. The U. S. , Germany, France, the U. K. , China, India and South Korea are the main global markets for sustainable packaging due to stringent government regulations and awareness. Germany, France and the U. K. have excellent recycling regulations and extended producer responsibilitie
Global Smart Transportation Market Global Smart Transportation Market Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Smart Transportation Market Size, Share & Trends Analysis Report by Solution (Ticketing Management System, Parking Management System), by Service, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering. The global smart transportation market size is estimated to reach USD 285.12 billion by 2030, growing at a CAGR of 12.6% from 2022 t
Global Transdermal Skin Patches Market Global Transdermal Skin Patches Market Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Transdermal Skin Patches Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering. Global Transdermal Skin Patches Market is expected to reach US$ 9.6 billion in 2027 from $7.8 billion in 2021, growing at a CAGR of 3.52% Transdermal skin patches are a no
Major players in the orthopedic biomaterials market are Zimmer Biomet Holdings Inc. , Stryker Corporation, Victrex PLC (Invibio Ltd. ), Globus Medical Inc. , CAM Bioceramics B. V. , Heraeus Holding GmbH, Exactech Inc.New York, May 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Orthopedic Biomaterials Global Market Report 2022" - https://www.reportlinker.com/p06280851/?utm_source=GNW , Collagen Matrix Inc., Evonik Industries AG, and Koninklijke DSM N.V. (DSM Bi
The iPhone 14 release date is on track, despite rumours to the contrary, according to a reputable Apple analyst. It has requested around 220 million of the new devices, the report claimed – roughly in line with the previous year.
Major players in the pain management devices and therapies market are Abbott Laboratories, AstraZeneca, Pfizer, Boston Scientific Corporation, GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd, Medtronic PLC, Novartis AG, Baxter International Inc, and Johnson & Johnson.New York, May 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pain Management Devices And Therapies Global Market Report 2022" - https://www.reportlinker.com/p06280840/?utm_source=GNW The g
Audacious Accelerator Program Begins with Six-Month ‘Gamified’ Startup Competition Rewarding Sales Numbers over Pitching Skills The Startup Race Launches Hackathon to Kick-Off its 2022 £10,000 UK Startup Race The Startup Race Accelerator announced today its 48-hour Online Hackathon opens at 5pm on Friday, May 27 2022, as preparation for its £10,000 Startup Race, which begins June 14, 2022. More than 350 fast-growth entrepreneurs have so far registered for the Pre-Hackathon programme on Leanstack
Shareholders have reelected all of McDonald's Corp's directors, the company said on Thursday, ending a boardroom battle with billionaire investor Carl Icahn who had sought to win two board seats and shine a spotlight on his campaign over animal welfare. Preliminary tallies showed shareholders backed all 12 of McDonald's directors and that Icahn's two nominees received approximately 1% of the vote, the company said. "McDonald’s shareholders value a Board of Directors with a breadth of experiences to advise the Brand on the multitude of issues that can impact the business on a daily basis," board chairman Enrique Hernandez, Jr. said in a statement.